Bubble Bubble, Toil and Trouble – or Not?
In the wake of bursting housing and financial bubbles, it is little wonder why there is widespread speculation throughout the venture capital and private equity…
Posted by
Safeguard Insights
Clarient and Avid Radiopharmaceuticals Complete Acquisitions
Earlier this quarter, we announced that partner companies Clarient (Nasdaq: CLRT) and Avid Radiopharmaceuticals had signed definitive agreements to be acquired by GE Healthcare and…
Posted by
Eli Lilly Agrees to Acquire Safeguard Scientifics Partner Company Avid Radiopharmaceuticals
For the second time in as many weeks, I am pleased to announce that a major player in the pharmaceutical industry has recognized the value…
Posted by
Partner Company Clarient (Nasdaq: CLRT) to be Acquired by GE Healthcare for $587 Million
At Safeguard Scientifics, our strategy is to provide growth capital for entrepreneurial and innovative life sciences and technology companies, build value in those companies and…
Posted by
The Current Competitive M&A Climate
As reported recently in The Wall Street Journal, companies are sitting on nearly $2 trillion of cash. As a result, shareholders are beginning to ask…
Posted by
IPOs: A Financing Event
On the heels of continued IPO activity, there has been a flurry of media coverage — both positive and negative — regarding the companies that…
Posted by
Exit Environment and Valuations
According to new research published in this month’s Journal of Business Venturing, privately held businesses that start the initial public offering (IPO) process at the…
Posted by
